{"type":"rich","version":"1.0","title":"32: Why Pharmaceutical Companies Face an Existential M&A Crisis","author_name":"Deal of the Week","author_url":"https://bloomberg.com/podcasts/deal_of_the_week","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/deal-of-the-week/32-why-pharmaceutical-companies-face-an-existentia/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"32: Why Pharmaceutical Companies Face an Existential M&A Crisis\"></iframe>","width":600,"height":180}